CLXT News
Archived Headlines
- Calyxt prices IPO at $8, the low end of the slashed range 07/19/17
- US IPO Week Ahead: Diverse 6-IPO week has yoga, pet meds and gene-edited crops 07/14/17
- Cream of the gene-edited crop: Calyxt sets terms for $100 million IPO 07/10/17
- New Genes: Crop gene-editor Calyxt files for a $50 million IPO 06/23/17
Bumper crop of IPOs: Bioceres sets terms for $130 million
Bioceres, which sells biologic agrochemicals and develops seed productivity traits in Argentina, announced terms for its IPO on Tuesday. It plans to list on the NYSE and Argentina's BYMA under the symbol BIOX. The Rosario, Argentina-based company plans to...read more
Renaissance Capital's 3Q17 US IPO Market Review
IPO Market Enters Fourth Quarter with the Wind at its Back The US IPO market saw 29 IPOs raise $4.1 billion in the third quarter, a drop from the prior year period. Small-cap health care companies, mostly biotechs, made up almost half of all...read more
US IPO Week Ahead: 1 SPAC on the calendar as August slowdown sets in
One blank check company, Capitol Investment Corp. IV, is on the IPO calendar for the week ahead to raise $350 million. The slowdown in IPO activity marks the start of the annual August lull. Aside from the one SPAC, there will likely be no IPOs for the next four...read more
US IPO Weekly Recap: Investors remain discerning amid increased activity
After two slow weeks, IPO pricing activity picked up with four companies raising a combined $466 million. Investors remain discerning despite the increased activity; a Cellectis spinoff and a mortgage REIT both priced below their midpoints, and a yoga studio...read more